SUMMARY
The transcytosis of antigens across the gut epithelium by microfold cells (M cells) is important for the induction of efficient immune responses to some mucosal antigens in Peyer’s patches. Recently, substantial progress has been made in our understanding of the factors that influence the development and function of M cells. This review highlights these important advances, with particular emphasis on: the host genes which control the functional maturation of M cells; how this knowledge has led to the rapid advance in our understanding of M-cell biology in the steady-state and during aging; molecules expressed on M cells which appear to be used as “immunosurveillance” receptors to sample pathogenic microorganisms in the gut; how certain pathogens appear to exploit M cells to infect the host; and finally how this knowledge has been used to specifically target antigens to M cells to attempt to improve the efficacy of mucosal vaccines.
INTRODUCTION
A single layer of epithelial cells provides a protective barrier against the substantial bacterial burden within the intestinal lumen. However, the epithelia overlying the organized lymphoid follicles of the gut-associated lymphoid tissues (GALT) including the Peyer’s patches, their equivalents in the caecum and colon, and isolated lymphoid follicles (ILFs), are specialized for sampling the lumenal contents. Under steady-state conditions approximately 10 % of the epithelial cells within these follicle-associated epithelia (FAE) are microfold (M) cells1-3. These cells have unique morphological features including the presence of a reduced glycocalyx, irregular brush border and reduced microvilli. Furthermore, in contrast to the neighbouring enterocytes within the FAE, M cells are highly specialized for the phagocytosis and transcytosis of gut lumen macromolecules, particulate antigens and pathogenic or commensal microorganisms across epithelium (Figure 1). Following their transcytosis across the FAE, antigens exit into the intraepithelial pocket beneath the M-cell basolateral membrane which contains various populations of lymphocytes and mononuclear phagocytes (MNP, a heterogenous population of macrophages and classical dendritic cells4-6). This specialized microenvironment beneath the M-cell enables the efficient transfer of lumenal antigens to MNP7, 8. Studies show that in the absence of M cells, or antigen sampling by M cells, antigen-specific T-cell responses in the Peyer’s patches of mice orally-infected with Salmonella enterica serovar Typhimurium are reduced2, 9. Thus, the efficient M-cell-mediated sampling of gut lumenal antigens is considered an important initial step in the induction of some mucosal immune responses2, 7-9.
In this review we mostly describe the recent progress that has been made in our understanding of the immunobiology of M cells in the intestine, but it is important to note that M cells are not only restricted the FAE overlying the GALT. For example, cells with typical features of M cells have been reported in the murine nasal passage epithelium, identifying a novel, NALT-independent mode of antigen sampling in the respiratory tract10. In the intestine M cells have also been described within the villous epithelium8, 11,12, but whether these cells are functionally equivalent to those within the FAE overlying the organised lymphoid follicles remains to be determined13.
M cells differentiate from Lgr5+ stem cells in the crypts in a RANKL- and Spi-B dependent manner
Since M cells are considered to play an important role in the induction of specific mucosal immune responses in the Peyer’s patches2, 9, their manipulation may improve the efficacy of mucosal vaccines or help develop strategies to block transmission of some orally-acquired infections (discussed below). Many studies have therefore attempted to elucidate the molecular mechanisms which regulate M-cell differentiation in the gut epithelium. In the intestine almost all epithelial cell lineages develop from intestinal epithelial stem cells within the crypts. The dome-associated crypts surrounding the FAE, and the villous crypts at the base of the villi, each contain cycling leucine-rich repeat-containing G protein-coupled receptor-(Lgr5-) positive+ stem cells intermingled amongst Paneth cells14. These stem cells produce highly proliferative daughter cells which upon appropriate stimulation can differentiate into all the epithelial cell populations within the small intestine including the enterocytes, goblet cells, enteroendocrine cells, tuft cells and Paneth cells. Lineage-tracing studies using transgenic mice expressing a reporter gene (LacZ) under control of the Lgr5 promoter have confirmed that all the epithelial cells within the FAE, including M cells, are derived from the cycling Lgr5+ stem cells within the dome-associated crypts15-17 (Figure 2).
In the mouse intestine under steady-state conditions M cells are mostly confined to the FAE overlying the organized lymphoid follicles of the GALT. Since both the dome-associated crypts and the villous crypts throughout the intestine contain cycling Lgr5+ stem cells, additional signals from the cells beneath the FAE in the subepithelial dome (SED) are required to induce M-cell differentiation, and in doing so restrict these cells to the epithelia overlying organized lymphoid follicles. The TNF superfamily member receptor activator of NF-κB ligand (RANKL), signals via its receptor RANK (receptor activator of NF-κB), which is expressed by epithelial cells throughout the intestine. However, in the intestine RANKL is selectively expressed by the subepithelial stromal cells beneath the FAE18, 19. Analysis of RANKL-deficient mice, and administration of exogenous RANKL in vivo, show this cytokine is a critical factor that controls the differentiation of RANK-expressing enterocytes into M cells20. Under steady-state conditions, the only RANK-expressing intestinal epithelial cells that are exposed to sufficient RANKL from any source to respond in a detectable way are those in the FAE that are immediately above the RANKL-expressing subepithelial stromal cells. These data imply that in the context of M-cell differentiation, much of the RANKL-RANK signalling is delivered by the intact transmembrane cytokine following direct cell contact, rather than systemic dissemination of soluble RANKL. However, the possibility cannot be entirely excluded that both the membrane and soluble forms of RANKL are expressed by SED stromal cells. Accordingly, in the steady state, villous enterocytes situated distant from organized lymphoid structures are not exposed to enough RANKL to show any induction of the genes that regulate M cell-differentiation2, 20. Thus, the restriction of RANKL-expression to the subepithelial stromal cells ensures that the differentiation of Lgr5+ stem cells into M cells is spatially restricted to the FAE overlying GALT (Figure 2). Consistent with this theory, the systemic treatment of mice with RANKL induces the ectopic differentiation of enterocytes into M cells in the villous epithelium2, 20. To help to focus the effects of soluble RANKL to the overlying FAE, it is plausible that the range of its activity is further restricted by binding to osteoprotegerin, a secreted decoy receptor of RANKL21.
Distinct transcription factors control the expression of the sets of genes which ultimately determine the differentiation of crypt stem cell-derived progenitor cells into terminally differentiated intestinal epithelial cell populations. The same is true for M cells. The RANKL-induced, M cell-intrinsic, expression of the ETS transcription factor Spi-B specifically regulates the maturation of immature M cells into functionally mature M cells. While immature M-cell differentiation appeared to be unaffected in Spi-B-deficient (Spi-B−/−) mice, their FAE were are almost completely deficient in functionally mature M cells2, 15, 22. Thus, the terminal differentiation of M cells, as for other intestinal epithelial cell lineages, is regulated by a specific transcription factor (Figure 2).
Transcriptomic profiling studies have helped to identify those genes which are expressed by functionally mature M cells and regulated by Spi-B, including: Gp2, Tnfaip2 and Ccl9 (discussed below). Others such as Anxa5 and Marcksl1 (which encode for annexin A5 and MARCKS-like protein 1, respectively) are expressed by immature (differentiating) M cells in response to RANKL-stimulation but are regulated independently of Spi-B2, 13, 15, 23-26. Although their precise roles are uncertain, the immature M-cell markers such as ANXA5 and MARCKS-like protein 1 may be involved in cytoskeletal regulation to help adapt the differentiating epithelial cell towards one specialized for transcytosis27, 28.
An independent study has also investigated the requirement for Spi-B in M-cell differentiation22. In this study two distinct monoclonal Abs were used to detect M cells: one mAb specific for glycoprotein 2 (GP2, discussed below); and mAb NKM 16-2-4 which specifically recognises sites of α-1,2 fucosylation25, 29 and has a greater degree of specificity for M cells than the lectin Ulex europaeus agglutinin I (UEA-1, which also binds α-1,2 fucose with high-affinity). While the expression of the mature GP2+ M cells was completely absent in the FAE of Spi-B−/− mice, a small number of mAb NKM 16-2-4+ M cells were evident (~10 mAb NKM 16-2-4+ M cells/FAE)22. One interpretation of these apparently contradictory data is that a small population of M cells in the FAE may mature independently of Spi-B and as a consequence do not express proteins such as GP2 on their surfaces22. Alternatively, it is plausible that the remaining mAb NKM 16-2-4+ cells in the FAE of Spi-B−/− mice were not fully differentiated M cells, or represented other populations of fucosylated enterocytes.
M cells appear to be regularly spaced in the FAE implying that their distribution is highly regulated (Figure 1b). Indeed, while all the epithelial cells in the FAE derive from Lgr5+ stem cells15 and are exposed to high levels of RANKL-stimulation from the stromal cells in the SED20, only a proportion of the cells are destined to become M cells. Hsieh and colleagues have questioned how this distribution may be regulated30. Notch receptors and their ligands play important roles in determining cell fate and tissue patterning. For example, direct cell-cell signalling, where the expression of a Notch ligand by one cell, may influence the fate of an adjacent cell expressing a Notch receptor. Consistent with this role, Notch and the ligand Jagged1 also appear to influence the patterning of M cells across the FAE30. The optimal distribution of M cells across the FAE may be important to ensure efficient immune surveillance, while at the same time maintaining the integrity of the FAE.
Analysis of cleaved caspase-3 expression in the intestinal epithelia of rats suggested that almost all the epithelial cells within the villi appear to be undergoing apoptosis, whereas the onset of apoptosis within the FAE has been reported to be delayed31. The differentiation and maturation of M cells from Lgr5+ stem cells within the crypts takes ~3-4 days2, 20. Whether this apparent delay to the progression of apoptosis in the FAE enables M-cell differentiation to be sustained for longer periods is uncertain.
Lympho-epithelial factors influence M cell differentiation in the FAE
In addition to the important stimuli provided to the differentiating M cells in the FAE by SED stromal cells, lympho-epithelial cell interactions also influence their development. Indeed, a role for haematopoietic cells such as B cells in inducing M-cell differentiation is well established32, 33. In the small intestine the chemokine CCL20 is specifically expressed by the FAE34, and in Peyer’s patches it mediates the chemoattraction of CCR6-expressing lymphocytes and leukocytes towards the FAE35. Mice deficient in CCR6 (CCR6−/− mice), the sole receptor for CCL20, have a significantly reduced frequency of mature GP2+ M cells in the FAE36-38, implying that the impaired migration of CCR6-expressing lymphocytes or leukocytes towards the FAE impedes M cell differentiation due to reduced lympho-epithelial cell interactions. Alternatively, this may also be due to an altered cytokine milieu in the SED. In the Peyer’s patches a unique subset of CCR6hiCD11cint B cells has been reported to specifically migrate towards FAE-derived CCL20 and promote M-cell differentiation37 (Figure 2). In the absence of CCR6 these cells could not migrate towards the FAE and M-cell differentiation was impeded, whereas their transfer into CCR6−/− mice coincided with restored M-cell maturation. Further analysis shows that although mature M cells are dramatically reduced in the FAE of CCR6−/− mice, immature ANXA5-expressing M cells are retained36-38. These data imply that CCL20-CCR6-signaling blockade in CCR6−/− mice does not impact on the initial induction of M-cell differentiation, but specifically impedes their functional maturation. Enteroinvasive bacteria including S. Typhimurium and the pathogenic bacteria S. Enteritidis and Listeria monocytogenes39 have each been shown to induce CCL20 expression by intestinal epithelial cells. This pathogen-mediated stimulation of CCL20 expression may be part of the host’s response to infection to attempt to enhance the “immunosurveillance” of the gut lumen. Alternatively, these pathogens may exploit this potentially aid their uptake from the gut lumen by stimulating the differentiation of enterocytes into M cells.
The factors provided by B cells (or other haematopoietic cell populations) that stimulate M-cell differentiation are uncertain, but may involve signalling between B cells and the M cell progenitor cells via CD137L/CD1378, 40 or macrophage migration inhibitory factor41. The expression of CCL20 in the intestinal epithelium is rapidly induced by RANKL-stimulation (Figure 3) and enhanced by TNFR and LTβR stimulation2, 42-44. However, haematopoietic cell populations within Peyer’s patches, including the CD11c+ B cells, do not express RANKL37, and B cell-derived TNF and lymphotoxin are each dispensable for the development of the FAE and M cells45. While the above studies together provide a plausible model by which lympho-epithelial interactions may contribute to the functional maturation of M cells, it is important to note that M cell maturation can be induced in an in vitro “gut organoid” model system which contains only epithelial cell elements15. Although the in vivo environment may differ significantly from that of an in vitro gut organoid, these data suggest that these lympho-epithelial interactions most likely provide accessory factors that enhance M-cell differentiation (Figure 2).
M cells are equipped with an array of molecules to sample lumenal antigens
M cells provide an efficient portal through which gut lumenal antigens can be delivered to the underlying mucosal lymphoid tissues. In order to achieve this, M cells in contrast to enterocytes, have a high endocytic and transcytotic capacity. Whether the sampling and transcytosis of microoganisms/antigens by M cells occurs predominantly in a non-selective manner as a consequence of constitutive “bulk sampling” of the lumenal contents, specifically via receptor mediated endocytosis, or both is uncertain. However, data from many studies suggest that M cells express a variety of “immunosurveillance” receptors on their apical surfaces which enable them to sample a diverse range of microbial pathogens and antigens.
Glycoprotein 2
Independent sets of gene profiling experiments aimed at identifying molecules that were expressed highly by M cells, but not by other enterocyte populations, identified GP2 as a specific M-cell marker24, 25. This GPI-anchored protein is highly expressed on the apical surface of M cells and selectively binds to the FimH component of the type I pili on the outer membrane of certain pathogenic and commensal bacteria such as Eschericia coli and S. Typhmurium. In the absence of GP2 expression by M cells, the transcytosis of type-I-piliated bacteria was impeded9. Furthermore, GP2-dependent bacterial transcytosis by M cells was shown to be important for the immunosurveillance of FimH+ bacteria in the gut lumen9.
Uromodulin
A homolog of GP2, uromodulin (UMOD or Tamm-Horsfall protein, THP), has also been reported to be specifically expressed by M cells15, 22. Secreted UMOD is a urinary protein which can also bind specifically to type-I-piliated E. coli and may function to prevent these bacteria from binding to uroepithelial cells46. Although the expression of Umod by Peyer’s patch M cells is much lower than Gp2 their similar characteristics imply that each protein may aid the sampling of FimH+ bacteria in the gut lumen9, 22.
Cellular prion protein
Continuing with the immunosurveillance theme, the cellular prion protein (PrPC) is also expressed highly on the apical membrane of M cells26 and has been implicated in the sampling of microorganisms from the gut lumen47. The GPI-anchored PrPC protein is expressed highly by many cell populations in mammals, but its precise function remains uncertain as PrP-deficient mice do not show an obvious phenotype. The Gram-negative bacterium Brucella abortus is a facultative intracellular pathogen and can express the heat shock protein 60 (Hsp60) on its cell surface. Data show that PrPC can interact with Hsp60, and may play an important role in the binding and internalization of B. abortus into M cells47. Thus, PrPC may also act as an uptake receptor for pathogenic bacteria which express Hsp60.
Other M-cell-specific proteins
A number of other M-cell-specific proteins have been reported which may similarly selectively bind to components of potentially pathogenic microorganisms. However, experiments are required to determine their in vivo functions in M cells. ANXA5 is expressed by immature and mature M cells48, and can bind to Gram-negative bacteria with high affinity via the lipid A domain of LPS49. The endotoxin activity of LPS is blocked when bound to ANXA5 implying an important anti-inflammatory role to protect the host against LPS-mediated endotoxemia. Alternatively, it is plausible that ANXA5 on M cells by binding LPS acts as an uptake receptor for Gram-negative bacteria. However, further studies are necessary to determine whether the lipid A domain of LPS would be directly accessible to M-cell-associated membrane receptors, or whether lipid A only becomes accessible after bacterial degradation. Peptidoglycan recognition protein (PGLRP)-1 (encoded by Pglyrp1, also known as PGRP-S) is an innate pattern recognition protein that binds to bacterial peptidoglycan, and is expressed highly by M cells8. Little is known of the in vivo functions of the four mammalian PGLRPs, but PGLRP1 has bactericidal activity against Gram-positive bacteria and is not known to be involved in cell-signalling50. Whether the PGLRP1 secreted by M cells exhibits a similar bactericidal activity to help protect the host against internalized bacteria remains to be determined? The potential roles of other M-cell expressed proteins are less discernible such as fatty acid binding protein 551, clusterin52 and secretogranin V (encoded by Scg5, also known as Sgne-1)24.
A phage-display screen of potential M-cell ligands identified one peptide, termed “Co1”, which shared high sequence homology with the α1 helix of the outer membrane protein H (OmpH) of Yersinia enterocolitica53. The same region of OmpH is also homologous to that of an E. coli chaperone protein, Skp, which can act as a complement C5a receptor (C5aR) chemotactic ligand. Data from the combined analysis of an in vitro M-cell-like model and mouse Peyer’s patch M cells in vivo, have suggested that OmpH β1α1 binds to C5aR on the apical M-cell surface and enhances the transcytosis of antigens into M cells54. However, whether direct molecular interactions between OmpH β1α1 and C5aR (and homologous ligands) occur on M cells is uncertain.
Secretory IgA
Secretory IgA provides a first line of defence in the mucosal immune system by preventing the access of specific pathogens and their toxins across the intestinal epithelium, and is an important regulator of the composition of the commensal gut microflora55. For example, secretory IgA is essential for protection from the effects of lumenal cholera toxin exposure56. Secretory IgA can block lumenal pathogens from binding to gut epithelial cells and in doing so can provide protection against intestinal reovirus infection57. Similarly, secretory IgA may also mediate the lumenal trapping of certain bacteria such as Shigella flexneri retaining them within the mucus layer overlying the intestinal epithelium58. Prevention of infection against oral infection with S. typhimurium has also been described59. The targeting of secretory IgA-containing immune-complexes to M cells appears to lead to their subsequent transcytosis through to the MNP and lymphocytes in the SED60, 61. Thus, in addition to the role of secretory IgA in facilitating the immune-exclusion of lumenal pathogens and their antigens, the transcytosis of IgA by M cells may also aid antigen sampling and modulate mucosal immune responses. Whether the binding and uptake of secretory IgA and/or IgA-containing immune complexes by M cells occurs specifically is uncertain. No putative IgA receptor has been reported to be expressed by M cells. The possibility therefore cannot be excluded that the enhanced pinocytic and transcytotic activity of M cells alone is sufficient to efficiently internalize secretory IgA and/or IgA-containing immune complexes. Following their uptake from the gut lumen IgA-containing immune-complexes do not appear to disseminate beyond the mesenteric lymph nodes61. It is plausible that the secretory IgA-mediated, selective delivery of potential gut pathogens to Peyer’s patches, may act to enable antigen recognition under neutralizing and non-inflammatory conditions without causing widespread tissue dissemination.
Attraction to, and communication with, immune cells in the basolateral pocket
The M-cell basolateral pocket is a specialized microenvironment beneath the FAE which enables close interactions between M cells, MNP, B cells and T cells7, 8. These cellular associations ensure that transcytosed microorganisms or macromolecules are readily acquired by specific immune cell populations to induce an appropriate immune response. M cells may even establish intercellular communication channels in order to transport cellular components between themselves and the cells within the basolateral pocket62. Tunneling nanotubes (TNT) are thin membranous intercellular conduits which enable the transport of cellular components between cells. Pathogens may also exploit these TNT conduits to aid their dissemination between host cells63, 64 or to manipulate the host’s response to infection by shuttling pathogen-derived immunosuppressive factors from infected cells to immune cell populations65. Tumour necrosis factor alpha-induced protein 2 (TNFAIP2, also known as M-Sec) is expressed specifically by mature M cells in a Spi-B-dependent manner2, 24. In Peyer’s patches TNFAIP2 is associated with TNT-like structures which appear to interconnect the M cells in the FAE62. Data show that TNFAIP2 acts as a key regulator of TNT formation between immune cells. Thus, the close association of M cells with MNP raises the possibility that some microorganisms or macromolecules may be directly transferred from the gut lumen to MNP via M-cell-derived TNT.
Chemokines and chemokine receptors play important roles in attracting lymphocytes and leukocytes to lymphoid tissues and controlling their positioning within them. In addition to CCL2034, several other chemokines are also expressed by the FAE, some of them specifically by M cells including CCL92, 25, 66 and CXCL1625, 67 (Figure 3). Retrospective analysis of the magnitude of all the chemokine encoding genes expressed by microarray data sets derived from Peyer’s patch M cells25, the FAE26 and RANKL-stimulated villous epithelia2 also indicates significant expression of CXCL11 when compared to the small intestine villous epithelium. The detection of a specific set of chemokines implies their expression is regulated by an underlying transcriptional program.
The wide range of chemokines and receptors expressed in mammals can lead to redundancy whereby several chemokines may bind and activate certain chemokine receptors. However, despite this apparent redundancy, mice deficient in the sole receptor for CCL20 (CCR6−/− mice) show a significant deficiency in M-cell maturation in the FAE36, 37. These data suggest that the other FAE- and M-cell-expressed chemokines most likely have accessory roles, such as the attraction of specific cell populations to the basolateral pocket to sample antigens and mount an immune response. The chemokine CCL9 appears to be preferentially expressed by mature M cells and may aid the recruitment of CD11b+ MNP to the SED of Peyer’s patches2, 66. CXCL16 expression may promote interactions between the FAE and CXCR6-expressing T cells67, and may plausibly also act as an antimicrobial peptide in the mucosal epithelium68. CCL25 expression may help mediate the homing of IgA antibody-secreting cells69, whereas CXCL11 may stimulate the attraction of CXCR3-expressing Th1 cells70.
Pathogens can exploit M cells to invade the host
Pathogenic microorganisms have evolved a wide range of mechanisms to evade or even exploit immune cells to infect the host. M cells are no exception to this as their efficient transcytotic activity is exploited by numerous pathogens to breach the gut epithelium. In the absence of M cells, oral infections with Y. enterocolitica36, prions71 or retrovirus33 are blocked or impeded. A role for M cells as portals for the entry of Listeria monocytogenes72, Mycobacterium avium subsp. paratuberculosis73, 74, S. Typhimurium75, human immunodeficiency virus type 176, influenza virus77, polio virus78 and reovirus79 have also been described. Staphylococcus aureus secretes a number of virulence factors such as the enterotoxins which can help subvert the host immune system. Data from in vitro studies imply that M cells may also aid the passage of staphylococcal enterotoxin A across the gut epithelium80. Together, these examples show that whereas the sampling of intestinal bacteria by M cells may be important for the induction of specific immunity in Peyer’s patches, this function has the potential to be a critical Achilles heel by enabling the safe passage of some pathogenic microorganism or their toxins across mucosal epithelia.
Pathogens can manipulate M cells to invade the host
While some pathogenic microorganisms may use molecules expressed on the apical surfaces M cells as invasion receptors to infect the host, others appear to have evolved mechanisms that exploit the plasticity of enterocytes to specifically induce M-cell differentiation in the gut epithelium. For example, apparent increases in M-cell-density or antigen transcytosis in the FAE have been described following exposure to S. Typhimurium81 and Streptococcus pneumoniae R36a82, 83.
The RANKL- and Spi-B-dependent differentiation of M cells from immature precursors in the crypts typically takes approximately 4 days2, 84, yet the studies above suggest that some pathogenic bacteria can achieve this within hours of exposure81-83. These characteristic suggest that it is highly unlikely that terminally-differentiated enterocytes or crypt stem cells could be converted by bacteria into mature M cells in such a short time-frame. A more plausible explanation is that the bacteria produce factors which act on cells in the FAE that are already destined to become functionally mature M cells (eg: immature, differentiating M cells). Recent data support this hypothesis, and show how a specific factor secreted by S. Typhimurium is used by the bacterium to enable the rapid trans-differentiation of FAE enterocytes into M cells to permit host invasion3. Specifically, the SPI-1 encoded type III effector protein SopB secreted by S. Typhimurium induced the epithelial-mesenchymal transition of FAE enterocytes into M cells. This cellular trans-differentiation occurred via the SopB-dependent activation of Wnt/β-catenin signalling and led to the induction of both RANKL and its receptor RANK. The autocrine RANKL-RANK activation of the cells induced the expression of Spi-B and also the epithelial-mesenchymal transition-regulating transcription factor Slug (encoded by Snai2) that triggered the FAE enterocytes to trans-differentiate into M cells3.
Aging impedes the functional maturation of M cells
The mucosal immune response in the intestine is significantly compromised by aging85-88. This age-related decline in immune competence is associated with diminished antigen-specific IgA antibody titres in the intestinal lumen86, 89 and a decreased ability to generate tolerance to harmless antigens87. Despite the important role of M cells in mucosal immunity in Peyer’s patches, nothing was known about how aging influenced their development and function. Using an immunosenescent mouse model we have recently shown that there is a dramatic decline in the functional maturation of GP2+ M cells in the Peyer’s patches of aged mice (≥ 600 days old). Furthermore, the transcytosis of particulate antigen across the FAE was likewise impeded38. In order to understand the mechanism underlying this aging-related decline in M-cell status, we also examined effects on the stimuli responsible for their induction and maturation. Aging did not affect RANKL expression by the SED stromal cells or the initial induction of M cell differentiation, but specifically impaired the expression of Spi-B and down-stream functional maturation of GP2+ M cells. Expression of the chemokine CCL20 was also reduced in the FAE of aged Peyer’s patches, consistent with data from an independent study of the effects of aging on ILFs90. As a consequence of the impaired CCL20 expression, the attraction cells (including the “M-cell-inducing” CD11c+ B cells37) towards the FAE was impaired. Since both the M-cell intrinsic expression of Spi-B2, 15, 22 and CCL20-CCR6 stimulation36, 37 each play important roles in M-cell differentiation, the effects of aging on Spi-B and CCL20 expression appear to dramatically impede the functional maturation of M cells.
Further studies are required to determine whether this aging-related deficiency in the mucosal immune system’s ability to sample lumenal antigens contributes to the aging-related decline in impaired antigen-specific mucosal immune responses86. However, since several pathogens such as S. Typhimurium75 and prions71 (as described above) exploit M cells to invade the host, the effects of ageing on M-cell status may paradoxically also have unexpected protective benefits. For example, the effects of aging on M-cell status may impede the early M-cell-dependent uptake of these pathogens into the Peyer’s patches, and in doing so significantly reduce disease susceptibility91, 92.
M-cell-binding ligands as novel mucosal vaccine targets
The significant advances that have been made in the identification of M-cell-specific surface markers or “immunosurveillance” receptors have focussed attention on the development systems to specifically deliver antigens to M cells in order to improve the efficacy of mucosal vaccines. A number of examples are discussed below. Lectins: The lectin UEA-1 binds to sites of α-1,2 fucosylation on the surfaces of M cells with high-affinity. Initial attempts using UEA-1 to target antigen to M cells showed that such approaches were effective in inducing antigen-specific mucosal IgA responses93-96. Along a similar theme, oral vaccination with antigen-encapsulated liposomes coupled to UEA-1 (termed lectinized liposomes) also led to increased uptake by Peyer’s patch M cells and the induction of higher antigen specific secretory IgA responses97.
Alternative approaches to target antigens to the α(1,2)-fucose-containing carbohydrate moiety on M cells have also been explored, for example, by using the non-toxic, small molecular UEA-1 mimetic, tetragalloyl-D-lysine dendrimer98. The mAb NKM 16-2-4 specifically recognises the α(1,2)-fucose-containing carbohydrate moiety on M cells with a greater affinity than that of UEA-1. Oral vaccine formulations comprising antigen coupled to mAb NKM 16-2-4 (with cholera toxin as a mucosal adjuvant) have been shown to be effective in inducing high antigen-specific mucosal IgA responses. Furthermore, oral vaccination with botulinum toxin-conjugated mAb NKM 16-2-4 induced protective immunity against oral exposure to a lethal toxin dose29.
Claudin 4
Although claudin 4 is a component of tight junctions, this protein may also be redistributed to the cytoplasm of M cells and play a role in endocytosis. A peptide derived from the c-terminal domain of the Clostridium perfringens enterotoxin binds to the external domain of claudin 4 and can mediate uptake by M cells in vivo99, 100. Furthermore, this claudin 4-binding peptide when coupled to antigen is effective in enhancing mucosal antigen-specific secretory IgA responses after intranasal immunization100.
C5aR ligands
As described above, the M-cell ligand “Co1” shared high sequence homology with OmpH of Y. enterocolitica, and each of these peptides appeared to bind to a C5aR on the apical surface of M cells54. The conjugation of antigens to either Co1 or OmpH could mediate their delivery to M cells in Peyer’s patches and induce enhanced mucosal immune responses after oral administration53, 54.
Reovirus hemagglutinin protein σ1
DNA vaccines have also been shown to confer protective immunity against a range of pathogenic microrganisms, but this approach has proved to be poor at inducing mucosal immunity. M-cell targeting has also been explored to attempt to improve the efficiency of the delivery of a DNA vaccine to a mucosal inductive tissue. Since reovirus is considered to bind M cells in vivo79, a recombinant reovirus hemagglutinin protein σ1 conjugated to polylysine was used to target a DNA vaccine to NALT M cells101. Intranasal immunization with protein σ1-polylysine-DNA was effective in inducing prolonged antigen-specific mucosal IgA responses, illustrating that M-cell targeted peptide or DNA vaccinations may each represent effective means of inducing antigen-specific mucosal immunity.
However, in addition to their role in the induction of specific mucosal immunity, M cells may also be involved in the induction of oral tolerance. Independent studies show that mucosal administration of low doses of reovirus protein σ1 conjugated to ovalbumin (OVA) induced systemic unresponsiveness and failed to elicit an OVA-specific mucosal immune response. Under these conditions the mice were shown to be tolerogenic to OVA and were resistant to peripheral challenge due to the generation of antigen-specific regulatory T cells102, 103.
Concluding remarks
Significant recent advances have been made in the identification of M-cell-specific surface markers, and the characterization of the range of pathogen-derived ligands these “immunosurveillance” receptors can bind. By using similar approaches to those described above it may be possible to significantly improve the efficacy and specificity of the M-cell targeting and elicit long-lived and protective mucosal immunity, or tolerance. The identification of the molecular mechanisms that some pathogens use to exploit M cells to invade the host may also lead to the development of specific strategies to block the initial host colonisation. While the targeted delivery of vaccine antigens to M cells offers potential as an effective means of inducing antigen-specific mucosal immune responses, the observation that the functional maturation of M cells is dramatically impaired in aged mice implies that these strategies may be much less effective when used to immunize the elderly38. An understanding of the molecular mechanism that underpins this aging-related decline in M cell status will help identify novel approaches to stimulate M cell differentiation and potentially improve mucosal immunity in the elderly.
The use of various M-cell-deficient mouse models has greatly improved our understanding of the immunobiology of M cells in immunity and disease pathogenesis in vivo. However, in many of these instances the possibility that M-cell-independent factors significantly contribute to the effects described cannot be entirely excluded. For example, RANKL-neutralization dramatically depletes M cells in the FAE in vivo20. However, RANKL may influence gene expression by other cells in the FAE13 which may also play a role in the uptake of lumenal antigens104. Similarly, the maturation of M cells is impaired in the FAE of CCR6−/− mice36-38, but effects on mucosal immunity or disease susceptibility due to the reduced size of their Peyer’s patches or defective T-cell responses cannot be entirely excluded. The independent demonstrations that expression of the transcription factor Spi-B is critical for the functional maturation of M cells2, 15, 22 has identified the Spi-B−/− mouse as an alternative approach to study the immunobiology of M cells. However, Spi-B also plays an important roles in the differentiation of plasmacytoid DC and B cells105, 106. In order to completely avoid these off-target effects conditional knockout mice with genes encoding RANK or Spi-B specifically-ablated in the intestinal epithelium are crucial to study mucosal immunity in the specific absence of M cells.
An in vitro M-cell-like model system in which a monolayer of the differentiated human enterocyte cell line Caco-2 is cultivated with B cells has been widely used to study M cells32. However, although these cells display efficient transcytotic activity in contrast to the undifferentiated enterocytes, it is uncertain whether these co-cultivated epithelial cells accurately represent the many characteristics of M cells in vivo. Furthermore, analysis of the genes expressed by “M-cell induced” Caco-2 cells shows that while they express CCL20 highly, they lack expression of many mature M cell marker genes such as GP2 and SPIB (Table 1). Recently, exciting progress was reported on the development of a novel, potentially physiologically relevant in vitro M-cell model system. In this system, RANKL-stimulation induces M-cell differentiation in gut organoid cultures established from intestinal crypts or single Lgr5+ crypt stem cells15. As well as exhibiting high transcytotic activity, the range of genes expressed by these organoid cultures closely resembles those of M cells in vivo (Table 1). These M-cell containing organoid cultures offer a simple and physiologically relevant in vitro model system in which to study the immunobiology of M cells from a range of mammalian species.
Table 1.
Gene symbol | Gene title | Up-regulated in villous epithelium by RANKL (Fold Change)a |
Day of peak expression level |
Up-regulated in small intestinal organoids by RANKL in vitro (Fold Change)b |
Up-regulated in M-cell-like cells in vitro (Fold Change)c |
---|---|---|---|---|---|
Gp2 | glycoprotein 2 (zymogen granule membrane) |
46.9 | 3 | 56.5 | Not expressed |
Spib | Spi-B transcription factor (Spi- 1/PU.1 related) |
31.9 | 2 | 18.5 | Not expressed |
Anxa5 | annexin A5 | 12.7 | 2 | 35.5 | Unchanged |
Ccl20 | chemokine (C-C motif) ligand 20 |
11.3 | 2 | 158.8 | 8 |
Tnfaip2 | tumor necrosis factor, alpha- induced protein 2 (M-Sec) |
7.7 | 2 | 13.9 | Unchanged |
Ccl9 | chemokine (C-C motif) ligand 9 |
4.9 | 2 | 32.0 | n/a |
Prnp | prion protein | 3.7 | 2 | 60.2 | Unchanged |
Marcksl1 | MARCKS-like 1 | 3.6 | 1 | 7.0 | Unchanged |
These data (GSE37861)2 were performed on Affymetrix mouse gene 1.0 ST expression arrays. Fold-change in gene expression level at peak day when compared to controls (d 0).
These data were performed on Agilent 4x44K whole mouse genome expression arrays and equivalent gene probe sets were compared (GSE38785)15. Fold-change in gene expression when compared to unstimulated control organoids.
Performed on Affymetrix human genome U133 plus 2 expression arrays and equivalent gene probe sets were compared. Fold-change in gene expression by M-cell-like differentiated Caco-2 cells when compared to undifferentiated controls (GSE25330, GSE7745)115. n/a; an equivalent annotated probe set was not present on the array.
Finally, many studies have primarily focussed on M cells as the main sites of antigen sampling in mucosal epithelia, but several studies are challenging the assertion that this activity is so restricted (Figure 4). Data from the ultrastructural analysis of Peyer’s patches identified a novel, previously unrecognised, potentially important component of the normal machinery for antigen sampling in the GALT. This study suggested that FAE enterocytes can also acquire certain gut lumenal antigens, and exocytose the intravascular contents of their large late endosomes into the extracellular space of the SED where they are acquired by MNP104. Goblet cells are situated throughout mucosal epithelia and until recently were mainly considered to function as mucin secreting cells. However, an elegant study shows that intestinal goblet cells can also function as passages for the delivery of low molecular weight soluble antigens to CD103+ MNP in the lamina propria107. The sampling of lumenal antigens may also not be entirely restricted to epithelial cell populations. Although the incidence is rare in the steady-state, certain inflammatory stimuli appear to recruit MNP from the lamina propria to the gut epithelium where they insert their dendrites through the tight junctions between enterocytes to directly sample the luminal contents108, 109. In addition to this “periscoping” activity, another study has even proposed that MNP sample lumenal antigens by extending their dendrites directly through “transcellular pores” in the M cells themselves7.
The precise immunological consequences of these alternative antigen sampling mechanisms are uncertain and require further analysis. Unlike macrophages which rapidly phagocytose microorganisms and destroy them in their phagosomes, classical DC appear to be equipped with both degradative and nondegradative antigen uptake pathways to facilitate antigen presentation to both T and B cells110, 111. Indeed, classical DC can capture and retain unprocessed antigen in vitro and in vivo and can transfer this antigen to naïve B cells to initiate a specific antibody response112. Viable commensal bacteria and unprocessed antigen can also be recovered from classical DC migrating within afferent mesenteric lymph113, 114. These contrasting characteristics raise the question of whether the cells through which antigens are initially sampled across the intestinal epithelium (M cells, enterocytes, goblet cells), determine whether lumen antigens are initially transferred directly into Peyer’s patches (such as after M-cell-mediated transcytosis) or into villi and onwards to the mesenteric lymph nodes. Similarly, it is also plausible that in the steady-state these routes also direct lumenal antigens to specific MNP populations, and as a consequence, fundamentally influence the nature of the immune response directed to those antigens.
ACKNOWLEDGEMENTS
This work was supported by project (BB/J014672/1; BB/K021257/1) and Institute Strategic Programme Grant (BB/J0004332/1) funding from the Biotechnology and Biological Sciences Research Council. I.R.W. was supported by grant funding from the National Institutes of Health (DK064730). We thank Dr. Atsushi Kobayashi (Tohoku University Graduate School of Medicine, Sendai, Japan) for immunohistochemistry expertise.
Footnotes
The authors declare no competing financial conflict of interest.
REFERENCES
- 1.Lorenz RG, Newberry RD. Isolated lymphoid follicles can function as sites for induction of mucosal immune responses. Ann. New York Acad. Sci. 2004;1029:44–57. doi: 10.1196/annals.1309.006. [DOI] [PubMed] [Google Scholar]
- 2.Kanaya T, et al. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat. Immunol. 2012;13:729–736. doi: 10.1038/ni.2352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tahoun A, et al. Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion. Cell Host & Microbe. 2012;12:645–666. doi: 10.1016/j.chom.2012.10.009. [DOI] [PubMed] [Google Scholar]
- 4.Mabbott NA, Baillie JC, Hume DA, Freeman TC. Meta-analysis of co-expressed gene signatures in mouse leukocyte populations. Immunobiology. 2010;215:724–736. doi: 10.1016/j.imbio.2010.05.012. [DOI] [PubMed] [Google Scholar]
- 5.Bradford BM, Sester D, Hume DA, Mabbott NA. Defining the anatomical localisation of subsets of the murine mononuclear phagocyte system using integrin alpha X (ITGAX) and colony stimulating factor 1 receptor (CSF1-R) expression fails to discriminate dendritic cells from macrophages. Immunobiology. 2011;216:1228–1237. doi: 10.1016/j.imbio.2011.08.006. [DOI] [PubMed] [Google Scholar]
- 6.Hume DA, Mabbott N, Raza S, Freeman TC. Can DCs be distinguished from macrophages by molecular signatures. Nat. Immunol. 2013;14:187–189. doi: 10.1038/ni.2516. [DOI] [PubMed] [Google Scholar]
- 7.Lelouard H, Fallet M, De Bovis B, Meresse S, Gorvel JP. Peyer’s patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology. 2012;142:592–601. doi: 10.1053/j.gastro.2011.11.039. [DOI] [PubMed] [Google Scholar]
- 8.Wang J, Gusti V, Saraswati A, Lo DD. Convergent and divergent development among M cell lineages in mouse mucosal epithelium. J. Immunol. 2011;187:5277–5285. doi: 10.4049/jimmunol.1102077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hase K, et al. Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune responses. Nature. 2009;462:226–231. doi: 10.1038/nature08529. [DOI] [PubMed] [Google Scholar]
- 10.Kim DY, et al. The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens. J. Immunol. 2011;186:4253–5262. doi: 10.4049/jimmunol.0903794. [DOI] [PubMed] [Google Scholar]
- 11.Vallon-Eberhard A, Landsman L, Yogev N, Verrier B, Jung S. Transepithelial pathogen uptake into the small intestinal lamina propria. J. Immunol. 2006;176:2465–2469. doi: 10.4049/jimmunol.176.4.2465. [DOI] [PubMed] [Google Scholar]
- 12.Jang MH, et al. Intestinal villous M cells: An antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA. 2004;101:6110–6115. doi: 10.1073/pnas.0400969101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kobayashi A, et al. Identification of Novel Genes Selectively Expressed in the Follicle-Associated Epithelium from the Meta-Analysis of Transcriptomics Data from Multiple Mouse Cell and Tissue Populations. DNA Res. 2012;19:407–422. doi: 10.1093/dnares/dss022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sato T, et al. Single Lgr5+ stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262–265. doi: 10.1038/nature07935. [DOI] [PubMed] [Google Scholar]
- 15.de Lau W, et al. Peyer’s patch M cells derive from Lgr5+ stem cells, require SpiB and are induced by RankL in cultured ‘organoids’. Mol. Cell Biol. 2012;32:3639–3647. doi: 10.1128/MCB.00434-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lopez-Garcia C, Klein AM, Simmons BD, Winton DJ. Intestinal stem cell replacement follows a pattern of neutral drift. Science. 2010;330:822–825. doi: 10.1126/science.1196236. [DOI] [PubMed] [Google Scholar]
- 17.Snippert HJ, et al. Intestinal crypt homeostasis results from neutral competition between symetrically dividing Lgr5 stem cells. Cell. 2010;143:134–144. doi: 10.1016/j.cell.2010.09.016. [DOI] [PubMed] [Google Scholar]
- 18.Taylor RT, et al. Lymphotoxin-independent expression of TNF-related activation-induced cytokine by stromal cells in cryptopatches, isolated lymphoid follicles, and Peyer’s patches. J. Immunol. 2007;178:5659–5667. doi: 10.4049/jimmunol.178.9.5659. [DOI] [PubMed] [Google Scholar]
- 19.Katakai T, et al. Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs. J. Immunol. 2008;181:6189–6200. doi: 10.4049/jimmunol.181.9.6189. [DOI] [PubMed] [Google Scholar]
- 20.Knoop KA, et al. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J. Immunol. 2009;183:5738–5747. doi: 10.4049/jimmunol.0901563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Trouvin A-P, Goeb V. Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clin. Interventions Aging. 2010;5:345–354. doi: 10.2147/CIA.S10153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sato S, et al. Transcription factor Spi-B-dependent and -independent pathways for the development of Peyer’s patch M cells. Mucosal Immunol. 2012 doi: 10.1038/mi.2012.122. in press. [DOI] [PubMed] [Google Scholar]
- 23.Lo D, et al. Cell culture modelling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer’s patch by expression of profiling of Caco-2/Raji co-cultures. Int. Immunol. 2004;16:91–99. doi: 10.1093/intimm/dxh011. [DOI] [PubMed] [Google Scholar]
- 24.Hase K, et al. Distinct gene expression profiles characterize cellular phenotypes of follicle-associated epithelium and M cells. DNA Res. 2005;12:127–137. doi: 10.1093/dnares/12.2.127. [DOI] [PubMed] [Google Scholar]
- 25.Terahara K, et al. Comprehensive gene expression profiling of Peyer’s patch M cells, villous M-like cells, and intestinal epithelial cells. J. Immunol. 2008;180:7840–7846. doi: 10.4049/jimmunol.180.12.7840. [DOI] [PubMed] [Google Scholar]
- 26.Nakato G, et al. New approach for M-cell-specific molecules by screening comprehensive transcriptome analysis. DNA Res. 2009;16:227–235. doi: 10.1093/dnares/dsp013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kenis H, et al. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 2004;279:52623–52629. doi: 10.1074/jbc.M409009200. [DOI] [PubMed] [Google Scholar]
- 28.Bjorkblom B, et al. c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cells. Mol. Cell Biol. 2012;32:3513–3526. doi: 10.1128/MCB.00713-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nochi T, et al. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J. Exp. Med. 2007;204:2789–2796. doi: 10.1084/jem.20070607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hsieh EH, Lo DD. Jagged1 and notch1 help edit M cell patterning in Peyer’s patch follicle epithelium. Dev. Comp. Immunol. 2012;27:306–312. doi: 10.1016/j.dci.2012.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Onishi S, et al. Immunohistochemical study on the delayed progression of epithelial apoptosis in follicle-associated epithelium of rat Peyer’s patch. J. Vet. Med. Sci. 2007;69:112301129. doi: 10.1292/jvms.69.1123. [DOI] [PubMed] [Google Scholar]
- 32.Kerneis S, Bogdanova A, Kraehenbuhl J-P, Pringualt E. Conversion by Peyer’s patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 1997;277:949–952. doi: 10.1126/science.277.5328.949. [DOI] [PubMed] [Google Scholar]
- 33.Golovkina TV, Schlomchik M, Hannum L, Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science. 1999;286:1965. doi: 10.1126/science.286.5446.1965. [DOI] [PubMed] [Google Scholar]
- 34.Iwasaki A, Kelsalla BA. Localization of distinct Peyer’s patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3, MIP-3ß, and secondary lymphoid organ chemokine. J. Exp. Med. 2000;191:1381–1394. doi: 10.1084/jem.191.8.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Cook DN, et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity. 2000;12:495–503. doi: 10.1016/s1074-7613(00)80201-0. [DOI] [PubMed] [Google Scholar]
- 36.Westphal S, et al. Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence on defective M-cell formation in vivo. Am. J. Pathol. 2008;172:671–680. doi: 10.2353/ajpath.2008.070393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ebisawa M, et al. CCR6hiCD11cint B cells promote M-cell differentiation in Peyer’s patch. Int. Immunol. 2011;23:261–269. doi: 10.1093/intimm/dxq478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kobayashi A, et al. The functional maturation of M cells is dramatically reduced in the Peyer’s patches of aged mice. Mucosal Immunol. 2013 doi: 10.1038/mi.2012.141. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sierro F, et al. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl. Acad. Sci. USA. 2001;98:13722–13727. doi: 10.1073/pnas.241308598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Hsieh EN, et al. CD137 is required for M cell functional maturation but not lineage commitment. Am. J. Pathol. 2010;177:666–676. doi: 10.2353/ajpath.2010.090811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Man AL, et al. Macrophage migration inhibitory factor plays a role in the regulation of microfold (M) cell-mediated transport in the gut. J. Immunol. 2008;181:5673–5680. doi: 10.4049/jimmunol.181.8.5673. [DOI] [PubMed] [Google Scholar]
- 42.Rumbo M, Sierro F, Debard N, Kraehenbuhl JP, Finke D. Lymphotoxin beta receptor signaling induces the chemokine CCL20 in intestinal epithelium. Gastroenterology. 2004;127:213–223. doi: 10.1053/j.gastro.2004.04.018. [DOI] [PubMed] [Google Scholar]
- 43.Wang J, Lopez-Fraga M, Rynko A, Lo DD. TNFR and LTβR agonists induce follicle-associated epithelium and M cell specific genes in rat and human intestinal epithelial cells. Cytokine. 2009;47:69–76. doi: 10.1016/j.cyto.2009.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sirard J-C, Didierlaurent A, Cayet D, Sierro F, Rumbo M. Toll-like receptor 5- and lymphotoxin b receptor-dependent epithelial cell Ccl20 expression involves the same NF-κB binding site but distinct NF-κB pathways and dynamics. Biochem. Biophys. Acta. 2009;1789:386–294. doi: 10.1016/j.bbagrm.2009.03.001. [DOI] [PubMed] [Google Scholar]
- 45.Tumanov AV, Kuprash DV, Mach JA, Nedospasov SA, Chervonsky AV. Lymphotoxin and TNF produced by B cells are despensable for maintenance of the follicle-associated epithelium but are required for development of lymphoid follicles in the Peyer’s patches. J. Immunol. 2004;173:86–91. doi: 10.4049/jimmunol.173.1.86. [DOI] [PubMed] [Google Scholar]
- 46.Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR. Tamm-Horsfall protein binds to type 1 fimbriated Eschericia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J. Biol. Chem. 2001;276:9924–9930. doi: 10.1074/jbc.M008610200. [DOI] [PubMed] [Google Scholar]
- 47.Nakato G, et al. Cutting edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptor. J. Immunol. 2012;189:1540–1544. doi: 10.4049/jimmunol.1103332. [DOI] [PubMed] [Google Scholar]
- 48.Verbrugghe P, et al. Murine M cells express annexin V specifically. J. Pathol. 2006;209:240–249. doi: 10.1002/path.1970. [DOI] [PubMed] [Google Scholar]
- 49.Rand JH, et al. Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity. mBio. 2012;3:e00292–00211. doi: 10.1128/mBio.00292-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Osanai A, et al. Mouse peptidogylcan recognition protein PGLYRP-1 plays a role in the host innate immune response against Listeria monocytogenes infection. Infect. Immun. 2011;79:858–866. doi: 10.1128/IAI.00466-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Suzuki R, et al. Localization of fatty acid binding protein of epidermal type common to dendritic cells and presumptive macrophages in Peyer’s patches and epithelial M cells of mouse intestine. Histochem Cell Biol. 2009;132:577–584. doi: 10.1007/s00418-009-0638-5. [DOI] [PubMed] [Google Scholar]
- 52.Verbrugghe P, Kujala P, Waelput W, Peters PJ, Cuvelier CA. Clusterin in human gut-associated lymphoid tissue, tonsils, and adenoids: localization to M cells and follicular dendritic cells. Histochem. Cell Biol. 2008;129:311–320. doi: 10.1007/s00418-007-0369-4. [DOI] [PubMed] [Google Scholar]
- 53.Kim SH, Seo KW, Kim J, Lee KY, Jang YS. The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination. J. Immunol. 2010;185:5787–5795. doi: 10.4049/jimmunol.0903184. [DOI] [PubMed] [Google Scholar]
- 54.Kim SH, et al. M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery. Eur. J. Immunol. 2011;41:3219–3229. doi: 10.1002/eji.201141592. [DOI] [PubMed] [Google Scholar]
- 55.Mantis NJ, Rol N, Corthesy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4:603–611. doi: 10.1038/mi.2011.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Lycke N, Erlandsson L, Ekman L, Schon K, Leanderson T. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection. J. Immunol. 1999;163:913–919. [PubMed] [Google Scholar]
- 57.Silvey KJ, Hutchings AB, Vajdy M, Petzke MM, Neutra MR. Role of immunoglobulin A in protection against reovirus entry into murine Peyer’s patches. J. Virol. 2001;75:10870–10879. doi: 10.1128/JVI.75.22.10870-10879.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Boullier S, et al. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J. Immunol. 2009;183:5879–5885. doi: 10.4049/jimmunol.0901838. [DOI] [PubMed] [Google Scholar]
- 59.Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect. Immun. 1992;60:1786–1792. doi: 10.1128/iai.60.5.1786-1792.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Rey J, Garin N, Spertini F, Corthesy B. Targeting of secretory IgA to Peyer’s patch dendritic cells and T cells after transport by intestinal M cells. J. Immunol. 2004;172:3026–3033. doi: 10.4049/jimmunol.172.5.3026. [DOI] [PubMed] [Google Scholar]
- 61.Kadaoui KA, Corthesy B. Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer’s patches with restriction to mucosal compartment. J. Immunol. 2007;179:7751–7757. doi: 10.4049/jimmunol.179.11.7751. [DOI] [PubMed] [Google Scholar]
- 62.Hase K, et al. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex. Nature Cell. Biol. 2009;11:1427–1432. doi: 10.1038/ncb1990. [DOI] [PubMed] [Google Scholar]
- 63.Gousset K, et al. Prions hijack tunnelling nanotubes for intercellular spread. Nature Cell. Biol. 2009;11:328–336. doi: 10.1038/ncb1841. [DOI] [PubMed] [Google Scholar]
- 64.Eugenin EA, Gaskill PJ, Berman JW. Tunelling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. Cell. Immunol. 2009;254:142–148. doi: 10.1016/j.cellimm.2008.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Xu W, et al. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic conduits and intestinal B cells via long-range intercellular conduits. Nat. Immunol. 2009 doi: 10.1038/ni.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Zhao X, et al. CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer’s patch CD11b+ dendritic cells. J. Immunol. 2003;171:2797–2803. doi: 10.4049/jimmunol.171.6.2797. [DOI] [PubMed] [Google Scholar]
- 67.Hase K, et al. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lymph-epithelial interaction in GALT. J. Immunol. 2006;176:43–51. doi: 10.4049/jimmunol.176.1.43. [DOI] [PubMed] [Google Scholar]
- 68.Kotarsky K, et al. A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the mucosa. Mucosal Immunol. 2010;3:40–48. doi: 10.1038/mi.2009.115. [DOI] [PubMed] [Google Scholar]
- 69.Hieshima K, et al. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J. Immunol. 2004;173:3668–3675. doi: 10.4049/jimmunol.173.6.3668. [DOI] [PubMed] [Google Scholar]
- 70.Lee JW, et al. Differential regulation of chemokines by IL-17 in colonic epithelial cells. J. Immunol. 2008;181:6536–6545. doi: 10.4049/jimmunol.181.9.6536. [DOI] [PubMed] [Google Scholar]
- 71.Donaldson DS, et al. M cell depletion blocks oral prion disease pathogenesis. Mucosal Immunol. 2012;5:216–225. doi: 10.1038/mi.2011.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Chiba S, et al. Listerial invasion protein internalin B promotes entry into ileal Peyer’s patches in vivo. Microbiol. Immunol. 2011;55:123–129. doi: 10.1111/j.1348-0421.2010.00292.x. [DOI] [PubMed] [Google Scholar]
- 73.Ponnusamy D, Periasamy S, Tripathi BN, Pal A. Mycobacterium avium subsp. paratuberculosis invades through M cell and enterocytes across ileal and jejunal mucosa of lambs. Res. Vet. Sci. 2012 doi: 10.1016/j.rvsc.2012.09.023. in press. [DOI] [PubMed] [Google Scholar]
- 74.Bermundez LE, Petrofsky M, Sommer S, Barletta RG. Peyer’s patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination. Infect. Immun. 2010;78:3570–3577. doi: 10.1128/IAI.01411-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Jones B, D, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer’s patches. J. Exp. Med. 1994;180:15–23. doi: 10.1084/jem.180.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Amerongen HM, et al. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J. Acquir. Immune Defic. Syndr. 1991;4:760–765. [PubMed] [Google Scholar]
- 77.Fujimura Y, et al. The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling. Virchows Arch. 2004;444:36–42. doi: 10.1007/s00428-003-0898-8. [DOI] [PubMed] [Google Scholar]
- 78.Takahashi Y, et al. Nonhuman primate intestinal villous M-like cells: an effective poliovirus entry site. Biochem. Biophys. Res. Commun. 2008;368:501–507. doi: 10.1016/j.bbrc.2008.01.120. [DOI] [PubMed] [Google Scholar]
- 79.Wolf JL, et al. Intestinal M cells: a pathway for entry of reovirus into the host. Science. 1981;212:471–472. doi: 10.1126/science.6259737. [DOI] [PubMed] [Google Scholar]
- 80.Maresca M, Dumay E, Fantini J, Caporiccio B. Selective transport of staphylococcal enterotoxin A through in vitro generated human M cells. Microbes Infect. 2007;9:1507–1510. doi: 10.1016/j.micinf.2007.07.006. [DOI] [PubMed] [Google Scholar]
- 81.Savidge TC, Smith MW, James PS, Aldred P. Salmonella-induced M-cell formation in germ-free mouse Peyer’s patch tissue. Am. J. Pathol. 1991;139:177–184. [PMC free article] [PubMed] [Google Scholar]
- 82.Borghesi C, Nicoletti C. Rapid appearance of M cells after microbial challenge is restricted at the periphery of the follicle-associated epithelium of Peyer’s patch. Lab. Invest. 1999;79:1393–1401. [PubMed] [Google Scholar]
- 83.Meynell HM, et al. Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer’s patch by exposure to Streptococcus pneumoniae R36a. FASEB J. 1999;13:611–619. doi: 10.1096/fasebj.13.6.611. [DOI] [PubMed] [Google Scholar]
- 84.Knoop KA, Butler BR, Kumar N, Newberry RD, Williams IR. Distinct developmental requirements for isolated lymphoid follicle formation in the small and large intestine. Am. J. Pathol. 2011;179:1861–1871. doi: 10.1016/j.ajpath.2011.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Schmucker D, Owen R, Outenreath R, Thoreux K. Basis for the age-related decline in intestinal mucosal immunity. Clin. Dev. Immunol. 2003;10:167–172. doi: 10.1080/10446670310001642168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Koga T, et al. Evidence for early aging in the mucosal immune system. J. Immunol. 2000;165:5352–5359. doi: 10.4049/jimmunol.165.9.5352. [DOI] [PubMed] [Google Scholar]
- 87.Kato H, et al. Lack of oral tolerance in ageing is due to sequential loss of Peyer’s patch cell interactions. Int. Immunol. 2003;15:145–158. doi: 10.1093/intimm/dxg011. [DOI] [PubMed] [Google Scholar]
- 88.Fujihashi K, McGhee JR. Mucosal immunity and tolerance in the elderly. Mech. Ageing Dev. 2004;125:889–898. doi: 10.1016/j.mad.2004.05.009. [DOI] [PubMed] [Google Scholar]
- 89.Dunn-Walters DK, Banerjee M, Mehr R. Effects of age in antibody affinity maturation. Biochem. Soc. Trans. 2003;31:447–448. doi: 10.1042/bst0310447. [DOI] [PubMed] [Google Scholar]
- 90.McDonald KG, Leach MR, Huang C, Wang C, Newberry RD. Aging impacts isolated lymphoid follicle development and function. Immun. Aging. 2011;8:1. doi: 10.1186/1742-4933-8-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Ren Z, et al. Effect of age on susceptibility to Salmonella Typhimurium infection in C57BL/6 mice. J. Med. Microbiol. 58:1559–1567. doi: 10.1099/jmm.0.013250-0. (20009) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Brown KL, Wathne GJ, Sales J, Bruce ME, Mabbott NA. The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice. J. Immunol. 2009;183:5199–5207. doi: 10.4049/jimmunol.0802695. [DOI] [PubMed] [Google Scholar]
- 93.Manocha M, et al. Enhanced mucosal and systemic immune responses with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. Vaccine. 2005;23:5599–5617. doi: 10.1016/j.vaccine.2005.06.031. [DOI] [PubMed] [Google Scholar]
- 94.Wang X, et al. Transgene vaccination using Ulex europaeus I (UEA-1) for targeted mucosal immunization against HIV-1 envelope. Vaccine. 2005;23:3836–3842. doi: 10.1016/j.vaccine.2005.02.023. [DOI] [PubMed] [Google Scholar]
- 95.Chionh YT, Wee JL, Every AL, Ng GZ, Sutton P. M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens. Infect. Immun. 2009;77:2962–2970. doi: 10.1128/IAI.01522-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Chionh YT, Sutton P. Targeting of whole killed bacteria to gastrointestinal M-cells induces humoral immunity in the female reproductive tract. Gut Microbes. 2010;1:42–44. doi: 10.4161/gmic.1.1.10096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Gupta PN, Vyas SP. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal administration. Colloids Surf. B Biointerfaces. 2011;82:118–125. doi: 10.1016/j.colsurfb.2010.08.027. [DOI] [PubMed] [Google Scholar]
- 98.Misumi S, et al. Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer. J. Immunol. 2009;182:6061–6070. doi: 10.4049/jimmunol.0802928. [DOI] [PubMed] [Google Scholar]
- 99.Rajapaksa TE, Stover-Hamer M, Fernandez X, Eckelhoefer HA, Lo DD. Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. J. Control. Release. 2010;142:196–205. doi: 10.1016/j.jconrel.2009.10.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Lo DD, Ling J, Eckelhoefer AH. M cell targeting by a claudin 4 targeting peptide can enhance mucosal IgA responses. BMC Biotechnol. 2012;12:7. doi: 10.1186/1472-6750-12-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Wu Y, et al. M cell-targeted DNA vaccination. Proc. Natl. Acad. Sci. USA. 2001;98:9318–9323. doi: 10.1073/pnas.161204098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Rynda A, et al. Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma 1. J. Immunol. 2008;180:5187–5200. doi: 10.4049/jimmunol.180.8.5187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Suzuki H, et al. Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology. 2008;135:917–925. doi: 10.1053/j.gastro.2008.05.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Kujala P, et al. Prion uptake in the gut: identification of the first uptake and replication sites. PloS Pathogens. 2011;7:e1002449. doi: 10.1371/journal.ppat.1002449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Sasaki I, et al. Spi-B is crucial for plasmacytoid dendritic cell function and development. Blood. 2012;120:4733–4743. doi: 10.1182/blood-2012-06-436527. [DOI] [PubMed] [Google Scholar]
- 106.Su GH, et al. Defective B cell receptor-mediated responses in mice lacking the Ets protein. EMBO J. 1997;16:7118–7129. doi: 10.1093/emboj/16.23.7118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.McDole JR, et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature. 2012;483:345–349. doi: 10.1038/nature10863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Rescigno M, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001;2:361–367. doi: 10.1038/86373. [DOI] [PubMed] [Google Scholar]
- 109.Farache J, et al. Liminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity. 2013 doi: 10.1016/j.immuni.2013.01.009. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 2005;307:1630–1634. doi: 10.1126/science.1108003. [DOI] [PubMed] [Google Scholar]
- 111.Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming to B cells. Immunity. 2005;23:503–514. doi: 10.1016/j.immuni.2005.09.013. [DOI] [PubMed] [Google Scholar]
- 112.Wykes M, Pombo A, Jenkins C, MacPherson GG. Dendritic cells interact directly with Naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 1998;161:1313–1319. [PubMed] [Google Scholar]
- 113.Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662–1665. doi: 10.1126/science.1091334. [DOI] [PubMed] [Google Scholar]
- 114.Huang F-P, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 2000;191:435–443. doi: 10.1084/jem.191.3.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Lapthorne S, et al. Differential intestinal M-cell gene expression response to gut commensals. Immunology. 2012;136:312–324. doi: 10.1111/j.1365-2567.2012.03581.x. [DOI] [PMC free article] [PubMed] [Google Scholar]